tradingkey.logo

Rigel Announces Settlement Agreement Resolving TAVALISSE® (Fostamatinib Disodium Hexahydrate) Patent Litigation

ReutersMar 27, 2025 12:22 PM

- Rigel Pharmaceuticals Inc RIGL.O:

  • RIGEL ANNOUNCES SETTLEMENT AGREEMENT RESOLVING TAVALISSE® (FOSTAMATINIB DISODIUM HEXAHYDRATE) PATENT LITIGATION

  • RIGEL PHARMACEUTICALS INC - UNDER SETTLEMENT, ANNORA TO SELL GENERIC TAVALISSE IN Q2 2032 OR EARLIER

  • RIGEL PHARMACEUTICALS INC - CO AND ANNORA TERMINATE ALL ONGOING LITIGATION REGARDING TAVALISSE PATENTS

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI